Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001564590-20-019772
Filing Date
2020-04-29
Accepted
2020-04-29 16:54:41
Documents
14
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A wve-10ka_20191231.htm   iXBRL 10-K/A 1970988
2 EX-31.1 wve-ex311_8.htm EX-31.1 5132
3 EX-31.2 wve-ex312_9.htm EX-31.2 5584
  Complete submission text file 0001564590-20-019772.txt   2291922

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA wve-20191231.xsd EX-101.SCH 5805
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE wve-20191231_lab.xml EX-101.LAB 27684
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wve-20191231_pre.xml EX-101.PRE 16640
14 EXTRACTED XBRL INSTANCE DOCUMENT wve-10ka_20191231_htm.xml XML 9045
Mailing Address 733 CONCORD AVENUE CAMBRIDGE MA 02138
Business Address 7 STRAITS VIEW #12-00, MARINA ONE EAST TOWER SINGAPORE U0 018936 617-949-2900
Wave Life Sciences Ltd. (Filer) CIK: 0001631574 (see all company filings)

EIN.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-37627 | Film No.: 20831208
SIC: 2834 Pharmaceutical Preparations